Wu A - Search Results

1

Correlation between alternative insulin resistance indexes and diabetic kidney disease: a retrospective study.

Mu X, Wu A, Hu H, Yang M, Zhou H. Mu X, et al. Among authors: wu a. Endocrine. 2024 Apr;84(1):136-147. doi: 10.1007/s12020-023-03574-6. Epub 2023 Oct 31. Endocrine. 2024. PMID: 37906402

2

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?

Mu X, Yang M, Ling P, Wu A, Zhou H, Jiang J. Mu X, et al. Among authors: wu a. Diabetes Metab Syndr Obes. 2022 Jan 29;15:247-256. doi: 10.2147/DMSO.S350233. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35125878 Free PMC article. Review.

3

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus.

Mu X, Wu A, Hu H, Zhou H, Yang M. Mu X, et al. Among authors: wu a. Front Endocrinol (Lausanne). 2022 Nov 28;13:1077632. doi: 10.3389/fendo.2022.1077632. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36518244 Free PMC article.

4

WITHDRAWN: Construction and evaluation of risk prediction model for kidney injury in patients treated with PD-1 inhibitors.

Lu P, Tian L, Wu A, Zhou H, Yang M. Lu P, et al. Among authors: wu a. Toxicol Appl Pharmacol. 2023 Apr 23:116530. doi: 10.1016/j.taap.2023.116530. Online ahead of print. Toxicol Appl Pharmacol. 2023. PMID: 37098382

5

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus.

Mu X, Wu A, Hu H, Zhou H, Yang M. Mu X, et al. Among authors: wu a. Diabetes Metab Syndr Obes. 2023 Jul 8;16:2061-2075. doi: 10.2147/DMSO.S417300. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37448880 Free PMC article.

6

Role of Interleukin 1 Receptor 2 in Kidney Disease.

Hu H, Wu A, Mu X, Zhou H. Hu H, et al. Among authors: wu a. J Interferon Cytokine Res. 2024 Apr;44(4):170-177. doi: 10.1089/jir.2023.0172. Epub 2024 Mar 22. J Interferon Cytokine Res. 2024. PMID: 38527174 Review.

7

Amorphous/Crystalline Urchin-Like TiO₂ SERS Platform for Selective Recognition and Efficient Identification of Glutathione.

Song X, Xu L, Li L, Meng X, Wang Y, Qiu L, Hu Y, Zhang M, Xiang L, Xi G, Wu A, Wang X, Lin J. Song X, et al. Among authors: wu a. Small. 2025 Jan 10:e2409400. doi: 10.1002/smll.202409400. Online ahead of print. Small. 2025. PMID: 39797480

8

DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1⁺ T-Lineage Cancers.

Cardle II, Raman J, Nguyen DC, Wang T, Wu AY, Sellers DL, Pichon TJ, Cheng EL, Kacherovsky N, Salipante SJ, Jensen MC, Pun SH. Cardle II, et al. Among authors: wu ay. ACS Appl Mater Interfaces. 2025 Jan 9. doi: 10.1021/acsami.4c17788. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39788927

9

Iron-Based Nanomaterials for Modulating Tumor Microenvironment.

Wang L, Zhang X, He L, Wei Y, Zhang Y, Wu A, Li J. Wang L, et al. Among authors: wu a. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb;17(1):e70001. doi: 10.1002/wnan.70001. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025. PMID: 39788569 Review.

10

Parkinsonism and Bilateral Facial Palsy after Chimeric Antigen Receptor T-Cell Therapy.

Wu AS, Hophing L, Gosse P, Motamed M, Bhella SD, Stewart K, Fasano A. Wu AS, et al. Mov Disord Clin Pract. 2025 Jan 9. doi: 10.1002/mdc3.14335. Online ahead of print. Mov Disord Clin Pract. 2025. PMID: 39780686 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,300 results

Search Page

Filters